Giacinto La Verde

Low absolute lymphocyte count is a poor prognostic factor in diffuse-large-B-cell-lymphoma

Maria Christina Cox, Italo Nofroni, Luigi Ruco et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2008 · 107 citations

Medicine, Oncology, Pathology +17

Multiple Myeloma Treatment in Real-world Clinical Practice: Results of a Prospective, Multinational, Noninterventional Study

Mohamad Mohty, Evangelos Terpos, María‐Victoria Mateos et al. · Clinical Lymphoma Myeloma & Leukemia · 2018 · 89 citations · Full text

Medicine, Hematology, Pharmacoeconomics +14

Pomalidomide, cyclophosphamide, and prednisone for relapsed/refractory multiple myeloma: a multicenter phase 1/2 open-label study

Alessandra Larocca, Vittorio Montefusco, Sara Bringhen et al. · Blood · 2013 · 88 citations · Full text

Medicine, Oncology, Pharmacotherapy +15

Bortezomib, thalidomide, and dexamethasone followed by double autologous haematopoietic stem-cell transplantation for newly diagnosed multiple myeloma (GIMEMA-MMY-3006): long-term follow-up analysis of a randomised phase 3, open-label study

Paola Tacchetti, Lucia Pantani, Francesca Patriarca et al. · The Lancet Haematology · 2020 · 58 citations

Medicine, Hematology, Pharmacotherapy +17

Percutaneous Vertebroplasty for Pain Management in Patients with Multiple Myeloma: Is Radiofrequency Ablation Necessary?

Gianluigi Orgera, Μiltiadis Krokidis, Marco Matteoli et al. · CardioVascular and Interventional Radiology · 2013 · 40 citations

Medicine, Orthopedic Surgery, Surgery +10